0 XP   0   0   0

Acrux Ltd
Buy, Hold or Sell?

Let's analyse Acrux together

PenkeI guess you are interested in Acrux Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Acrux Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Acrux Ltd

I send you an email if I find something interesting about Acrux Ltd.

Quick analysis of Acrux (30 sec.)










1. Valuation of Acrux (5 min.)




Live pricePrice per share (EOD)

A$0.05

2. Growth of Acrux (5 min.)




Is Acrux growing?

Current yearPrevious yearGrowGrow %
How rich?$6m$9.1m-$238k-2.7%

How much money is Acrux making?

Current yearPrevious yearGrowGrow %
Making money-$2.4m-$2.8m$443.6k?
Net Profit Margin-101.5%-462.6%--

How much money comes from the company's main activities?

3. Financial Health of Acrux (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#903 / 1215

Most Revenue
#526 / 1215

Most Profit
#554 / 1215

Most Efficient
#894 / 1215


Fundamentals of Acrux

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Acrux Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Acrux earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Acrux to the Biotechnology industry mean.
  • A Net Profit Margin of -145.1% means that $-1.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acrux Ltd:

  • The MRQ is -145.1%. The company is making a huge loss. -2
  • The TTM is -101.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-145.1%TTM-101.5%-43.6%
TTM-101.5%YOY-462.6%+361.1%
TTM-101.5%5Y-602.6%+501.1%
5Y-602.6%10Y-280.5%-322.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-145.1%-194.7%+49.6%
TTM-101.5%-273.6%+172.1%
YOY-462.6%-315.2%-147.4%
5Y-602.6%-539.0%-63.6%
10Y-280.5%-664.9%+384.4%
1.1.2. Return on Assets

Shows how efficient Acrux is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Acrux to the Biotechnology industry mean.
  • -30.5% Return on Assets means that Acrux generated $-0.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Acrux Ltd:

  • The MRQ is -30.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.5%TTM-21.7%-8.8%
TTM-21.7%YOY-23.0%+1.3%
TTM-21.7%5Y-15.3%-6.4%
5Y-15.3%10Y-4.8%-10.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.5%-12.4%-18.1%
TTM-21.7%-12.5%-9.2%
YOY-23.0%-10.9%-12.1%
5Y-15.3%-15.3%+0.0%
10Y-4.8%-17.6%+12.8%
1.1.3. Return on Equity

Shows how efficient Acrux is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Acrux to the Biotechnology industry mean.
  • -48.0% Return on Equity means Acrux generated $-0.48 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Acrux Ltd:

  • The MRQ is -48.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -30.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-48.0%TTM-30.3%-17.7%
TTM-30.3%YOY-32.5%+2.2%
TTM-30.3%5Y-20.0%-10.3%
5Y-20.0%10Y-6.5%-13.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-48.0%-15.2%-32.8%
TTM-30.3%-15.5%-14.8%
YOY-32.5%-13.1%-19.4%
5Y-20.0%-20.4%+0.4%
10Y-6.5%-20.9%+14.4%

1.2. Operating Efficiency of Acrux Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Acrux is operating .

  • Measures how much profit Acrux makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Acrux to the Biotechnology industry mean.
  • An Operating Margin of -104.1% means the company generated $-1.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acrux Ltd:

  • The MRQ is -104.1%. The company is operating very inefficient. -2
  • The TTM is -66.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-104.1%TTM-66.0%-38.1%
TTM-66.0%YOY-337.3%+271.3%
TTM-66.0%5Y-568.9%+502.9%
5Y-568.9%10Y-255.2%-313.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-104.1%-318.9%+214.8%
TTM-66.0%-267.4%+201.4%
YOY-337.3%-333.8%-3.5%
5Y-568.9%-517.0%-51.9%
10Y-255.2%-624.7%+369.5%
1.2.2. Operating Ratio

Measures how efficient Acrux is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Acrux Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.334-0.334
TTM-5Y3.954-3.954
5Y3.95410Y2.030+1.924
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.013-3.013
TTM-3.644-3.644
YOY0.3344.537-4.203
5Y3.9546.411-2.457
10Y2.0308.312-6.282

1.3. Liquidity of Acrux Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Acrux is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.02 means the company has $3.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Acrux Ltd:

  • The MRQ is 3.019. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.665. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.019TTM4.665-1.646
TTM4.665YOY5.227-0.562
TTM4.6655Y8.384-3.719
5Y8.38410Y5.917+2.467
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0194.559-1.540
TTM4.6654.993-0.328
YOY5.2276.149-0.922
5Y8.3846.306+2.078
10Y5.9176.588-0.671
1.3.2. Quick Ratio

Measures if Acrux is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Acrux to the Biotechnology industry mean.
  • A Quick Ratio of 2.89 means the company can pay off $2.89 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acrux Ltd:

  • The MRQ is 2.892. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.689. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.892TTM2.689+0.203
TTM2.689YOY2.843-0.154
TTM2.6895Y4.481-1.792
5Y4.48110Y3.944+0.537
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8923.881-0.989
TTM2.6894.502-1.813
YOY2.8435.772-2.929
5Y4.4815.816-1.335
10Y3.9446.032-2.088

1.4. Solvency of Acrux Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Acrux assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Acrux to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Acrux assets are financed with 36.4% credit (debt) and the remaining percentage (100% - 36.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Acrux Ltd:

  • The MRQ is 0.364. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.260. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.260+0.104
TTM0.260YOY0.282-0.022
TTM0.2605Y0.185+0.075
5Y0.18510Y0.172+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3640.311+0.053
TTM0.2600.298-0.038
YOY0.2820.269+0.013
5Y0.1850.377-0.192
10Y0.1720.409-0.237
1.4.2. Debt to Equity Ratio

Measures if Acrux is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Acrux to the Biotechnology industry mean.
  • A Debt to Equity ratio of 57.3% means that company has $0.57 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Acrux Ltd:

  • The MRQ is 0.573. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.362. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.573TTM0.362+0.212
TTM0.362YOY0.398-0.036
TTM0.3625Y0.246+0.116
5Y0.24610Y0.220+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5730.363+0.210
TTM0.3620.3620.000
YOY0.3980.277+0.121
5Y0.2460.424-0.178
10Y0.2200.463-0.243

2. Market Valuation of Acrux Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Acrux generates.

  • Above 15 is considered overpriced but always compare Acrux to the Biotechnology industry mean.
  • A PE ratio of -6.86 means the investor is paying $-6.86 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acrux Ltd:

  • The EOD is -6.462. Company is losing money. -2
  • The MRQ is -6.858. Company is losing money. -2
  • The TTM is -10.559. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-6.462MRQ-6.858+0.396
MRQ-6.858TTM-10.559+3.702
TTM-10.559YOY-15.073+4.513
TTM-10.5595Y-15.328+4.769
5Y-15.32810Y82.175-97.503
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.462-6.504+0.042
MRQ-6.858-7.165+0.307
TTM-10.559-8.417-2.142
YOY-15.073-19.810+4.737
5Y-15.328-18.328+3.000
10Y82.175-18.049+100.224
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Acrux.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Acrux Ltd:

  • The MRQ is -6.858. Very Bad. -2
  • The TTM is -10.555. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-6.858TTM-10.555+3.697
TTM-10.555YOY-4.302-6.253
TTM-10.5555Y-11.993+1.438
5Y-11.99310Y99.899-111.892
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.858-4.287-2.571
TTM-10.555-6.137-4.418
YOY-4.302-13.849+9.547
5Y-11.993-12.525+0.532
10Y99.899-11.713+111.612

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Acrux is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.64 means the investor is paying $1.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Acrux Ltd:

  • The EOD is 1.550. Good. +1
  • The MRQ is 1.645. Good. +1
  • The TTM is 1.931. Good. +1
Trends
Current periodCompared to+/- 
EOD1.550MRQ1.645-0.095
MRQ1.645TTM1.931-0.286
TTM1.931YOY3.491-1.559
TTM1.9315Y2.413-0.482
5Y2.41310Y6.059-3.646
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5501.991-0.441
MRQ1.6452.024-0.379
TTM1.9312.335-0.404
YOY3.4913.965-0.474
5Y2.4133.738-1.325
10Y6.0594.004+2.055
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Acrux Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Acrux Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.014-0.008-42%0.005-389%-0.006-57%-0.004-73%
Book Value Growth--0.6910.851-19%1.118-38%0.939-26%0.968-29%
Book Value Per Share--0.0320.047-32%0.048-34%0.069-54%0.112-72%
Book Value Per Share Growth--0.6910.851-19%1.118-38%0.939-26%0.968-29%
Current Ratio--3.0194.665-35%5.227-42%8.384-64%5.917-49%
Debt To Asset Ratio--0.3640.260+40%0.282+29%0.185+97%0.172+111%
Debt To Equity Ratio--0.5730.362+59%0.398+44%0.246+133%0.220+160%
Dividend Per Share----0%-0%-0%0.006-100%
Eps---0.008-0.009+13%-0.011+45%-0.011+51%-0.001-90%
Eps Growth--1.0001.018-2%0.703+42%0.855+17%0.939+6%
Free Cash Flow Per Share---0.008-0.008-1%-0.010+23%-0.008-4%0.002-487%
Free Cash Flow Per Share Growth--1.0001.084-8%0.841+19%0.816+23%1.093-9%
Free Cash Flow To Equity Per Share---0.008-0.008-1%0.001-1674%-0.009+7%0.008-209%
Free Cash Flow To Equity Per Share Growth--1.0000.438+128%1.487-33%0.728+37%1.075-7%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.663-40%
Intrinsic Value_10Y_max--0.028--------
Intrinsic Value_10Y_min---0.728--------
Intrinsic Value_1Y_max--0.008--------
Intrinsic Value_1Y_min---0.041--------
Intrinsic Value_3Y_max--0.019--------
Intrinsic Value_3Y_min---0.151--------
Intrinsic Value_5Y_max--0.027--------
Intrinsic Value_5Y_min---0.292--------
Net Profit Margin---1.451-1.015-30%-4.626+219%-6.026+315%-2.805+93%
Operating Margin---1.041-0.660-37%-3.373+224%-5.689+446%-2.552+145%
Operating Ratio----0%0.334-100%3.954-100%2.030-100%
Pb Ratio1.550-6%1.6451.931-15%3.491-53%2.413-32%6.059-73%
Pe Ratio-6.462+6%-6.858-10.559+54%-15.073+120%-15.328+124%82.175-108%
Peg Ratio---6.858-10.555+54%-4.302-37%-11.993+75%99.899-107%
Price Per Share0.049-6%0.0520.092-43%0.160-68%0.150-65%0.834-94%
Price To Total Gains Ratio-3.472+6%-3.685-4.543+23%-24.544+566%-12.499+239%45.768-108%
Profit Growth---0.759-100%0.350-100%-2.6950%-0.8100%
Quick Ratio--2.8922.689+8%2.843+2%4.481-35%3.944-27%
Return On Assets---0.305-0.217-29%-0.230-25%-0.153-50%-0.048-84%
Return On Equity---0.480-0.303-37%-0.325-32%-0.200-58%-0.065-87%
Total Gains Per Share---0.014-0.008-42%0.005-389%-0.006-57%0.002-784%
Usd Book Value--6047577.0008957765.525-32%9195776.600-34%13191202.485-54%21386484.313-72%
Usd Book Value Change Per Share---0.009-0.005-42%0.003-389%-0.004-57%-0.003-73%
Usd Book Value Per Share--0.0210.031-32%0.032-34%0.046-54%0.074-72%
Usd Dividend Per Share----0%-0%-0%0.004-100%
Usd Eps---0.005-0.006+13%-0.007+45%-0.008+51%0.000-90%
Usd Free Cash Flow---1562457.050-1544161.300-1%-1918600.456+23%-1501216.185-4%403670.775-487%
Usd Free Cash Flow Per Share---0.005-0.005-1%-0.007+23%-0.005-4%0.001-487%
Usd Free Cash Flow To Equity Per Share---0.006-0.005-1%0.000-1674%-0.006+7%0.005-209%
Usd Price Per Share0.033-6%0.0350.061-43%0.106-68%0.100-65%0.555-94%
Usd Profit---2901373.300-2453460.075-15%-2897090.4310%-2178366.841-25%-81449.352-97%
Usd Revenue--1999891.800848756.475+136%849130.706+136%539907.583+270%2619190.463-24%
Usd Total Gains Per Share---0.009-0.005-42%0.003-389%-0.004-57%0.001-784%
 EOD+3 -2MRQTTM+8 -28YOY+16 -215Y+14 -2210Y+8 -31

4.2. Fundamental Score

Let's check the fundamental score of Acrux Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.462
Price to Book Ratio (EOD)Between0-11.550
Net Profit Margin (MRQ)Greater than0-1.451
Operating Margin (MRQ)Greater than0-1.041
Quick Ratio (MRQ)Greater than12.892
Current Ratio (MRQ)Greater than13.019
Debt to Asset Ratio (MRQ)Less than10.364
Debt to Equity Ratio (MRQ)Less than10.573
Return on Equity (MRQ)Greater than0.15-0.480
Return on Assets (MRQ)Greater than0.05-0.305
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Acrux Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.047
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets14,302
Total Liabilities5,212
Total Stockholder Equity9,090
 As reported
Total Liabilities 5,212
Total Stockholder Equity+ 9,090
Total Assets = 14,302

Assets

Total Assets14,302
Total Current Assets10,016
Long-term Assets10,016
Total Current Assets
Cash And Cash Equivalents 5,831
Net Receivables 3,765
Other Current Assets 420
Total Current Assets  (as reported)10,016
Total Current Assets  (calculated)10,016
+/-0
Long-term Assets
Property Plant Equipment 2,556
Intangible Assets 375
Other Assets 1,730
Long-term Assets  (as reported)4,286
Long-term Assets  (calculated)4,661
+/- 375

Liabilities & Shareholders' Equity

Total Current Liabilities3,318
Long-term Liabilities1,894
Total Stockholder Equity9,090
Total Current Liabilities
Short-term Debt 224
Accounts payable 789
Other Current Liabilities 2,305
Total Current Liabilities  (as reported)3,318
Total Current Liabilities  (calculated)3,318
+/-0
Long-term Liabilities
Long term Debt Total 1,854
Other Liabilities 40
Deferred Long Term Liability 375
Long-term Liabilities  (as reported)1,894
Long-term Liabilities  (calculated)2,269
+/- 375
Total Stockholder Equity
Common Stock114,563
Retained Earnings -113,723
Accumulated Other Comprehensive Income 8,250
Total Stockholder Equity (as reported)9,090
Total Stockholder Equity (calculated)9,090
+/-0
Other
Capital Stock114,563
Cash And Equivalents5,831
Cash and Short Term Investments 5,831
Common Stock Shares Outstanding 285,365
Liabilities and Stockholders Equity 14,302
Net Debt -3,753
Net Invested Capital 9,090
Net Tangible Assets 9,090
Net Working Capital 6,698
Short Long Term Debt Total 2,078



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-30
> Total Assets 
12,019
0
0
18,356
0
0
0
12,846
10,686
10,686
9,758
9,758
33,480
33,480
31,094
31,094
27,755
27,755
23,234
23,234
20,083
20,083
20,369
20,369
43,521
43,521
41,267
41,267
39,111
39,111
34,950
34,950
32,310
32,310
83,605
83,605
175,545
175,545
58,995
58,995
55,485
55,485
58,499
58,499
46,369
46,369
52,895
52,895
76,697
76,697
53,221
53,221
45,143
45,143
48,495
48,495
49,705
49,705
53,371
53,371
58,459
58,459
47,306
47,306
37,161
37,161
32,490
32,490
28,473
28,473
24,433
24,433
20,082
20,082
0
17,836
0
17,620
0
23,327
0
17,161
0
14,302
14,302017,161023,327017,620017,836020,08220,08224,43324,43328,47328,47332,49032,49037,16137,16147,30647,30658,45958,45953,37153,37149,70549,70548,49548,49545,14345,14353,22153,22176,69776,69752,89552,89546,36946,36958,49958,49955,48555,48558,99558,995175,545175,54583,60583,60532,31032,31034,95034,95039,11139,11141,26741,26743,52143,52120,36920,36920,08320,08323,23423,23427,75527,75531,09431,09433,48033,4809,7589,75810,68610,68612,84600018,3560012,019
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
7,510
0
0
0
28,559
0
0
0
20,682
0
0
0
18,018
0
0
0
34,990
0
0
0
15,347
0
0
0
59,173
0
0
0
34,102
0
0
0
33,880
0
0
0
29,665
0
0
0
31,379
0
0
0
28,011
0
0
0
34,143
39,823
39,823
39,597
39,597
33,814
33,814
28,961
28,961
24,867
24,867
20,940
20,940
14,892
14,892
12,342
12,342
12,629
12,629
18,594
18,594
12,654
12,654
10,016
10,016
10,01610,01612,65412,65418,59418,59412,62912,62912,34212,34214,89214,89220,94020,94024,86724,86728,96128,96133,81433,81439,59739,59739,82339,82334,14300028,01100031,37900029,66500033,88000034,10200059,17300015,34700034,99000018,01800020,68200028,5590007,51000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
6,564
0
0
0
28,068
0
0
0
19,739
0
0
0
17,227
0
0
0
34,366
0
0
0
14,736
0
0
0
58,609
0
0
0
33,159
0
0
0
30,017
0
0
0
22,840
0
0
0
25,775
0
0
0
23,068
0
0
0
29,360
31,718
31,718
33,974
33,974
32,363
32,363
28,470
28,470
22,224
22,224
18,152
18,152
14,336
14,336
0
9,206
0
11,461
0
15,270
0
10,596
0
5,831
5,831010,596015,270011,46109,206014,33614,33618,15218,15222,22422,22428,47028,47032,36332,36333,97433,97431,71831,71829,36000023,06800025,77500022,84000030,01700033,15900058,60900014,73600034,36600017,22700019,73900028,0680006,56400000000000
       Net Receivables 
360
0
0
125
0
0
0
68
196
196
67
67
367
367
302
302
418
418
690
690
487
487
626
626
1,168
1,168
437
437
710
710
474
474
174
174
446
446
3,456
3,456
880
880
2,513
2,513
3,718
3,718
2,878
2,878
6,706
6,706
36,678
36,678
5,488
5,488
8,106
8,106
4,826
4,826
8,318
8,318
4,710
4,710
8,105
8,105
5,532
5,532
1,451
1,451
312
261
2,329
2,329
2,301
2,301
286
286
2,559
2,559
304
304
3,159
3,159
1,449
1,449
3,765
3,765
3,7653,7651,4491,4493,1593,1593043042,5592,5592862862,3012,3012,3292,3292613121,4511,4515,5325,5328,1058,1054,7104,7108,3188,3184,8264,8268,1068,1065,4885,48836,67836,6786,7066,7062,8782,8783,7183,7182,5132,5138808803,4563,4564464461741744744747107104374371,1681,16862662648748769069041841830230236736767671961966800012500360
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
2,248
0
0
0
2,535
0
0
0
2,552
0
0
0
2,351
0
0
0
6,277
0
0
0
19,603
0
0
0
24,432
0
0
0
24,893
0
0
0
24,619
0
0
0
23,230
0
0
0
21,842
0
0
0
20,484
0
0
0
19,228
0
0
0
7,709
0
0
0
3,529
0
0
0
3,493
0
0
0
5,494
0
0
0
4,733
0
0
0
4,286
4,2860004,7330005,4940003,4930003,5290007,70900019,22800020,48400021,84200023,23000024,61900024,89300024,43200019,6030006,2770002,3510002,5520002,5350002,24800000000000
       Property Plant Equipment 
55
0
0
310
0
0
0
1,281
1,146
1,146
1,039
1,039
1,012
1,012
1,157
1,157
1,160
1,160
1,248
1,248
1,092
1,092
1,052
1,052
1,022
1,022
912
1,201
1,426
1,426
1,772
2,376
1,810
1,810
1,024
1,986
169
169
126
24,357
85
85
110
24,178
103
103
93
22,884
85
85
78
21,591
64
64
92
92
143
143
262
262
410
410
778
778
822
822
845
845
997
997
906
906
3,200
3,200
3,100
3,100
2,874
2,874
2,644
2,644
2,633
2,633
2,556
2,556
2,5562,5562,6332,6332,6442,6442,8742,8743,1003,1003,2003,2009069069979978458458228227787784104102622621431439292646421,59178858522,8849310310324,178110858524,3571261691691,9861,0241,8101,8102,3761,7721,4261,4261,2019121,0221,0221,0521,0521,0921,0921,2481,2481,1601,1601,1571,1571,0121,0121,0391,0391,1461,1461,2810003100055
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
1,209
1,200
1,183
1,183
1,142
1,129
1,100
1,100
1,059
1,059
1,023
1,023
988
988
953
953
918
4,823
882
882
726
16,974
679
679
631
22,446
584
584
536
536
489
489
441
441
394
394
346
346
299
299
251
251
21,078
21,078
156
20,392
19,705
19,705
62
18,966
18,226
18,226
0
6,839
0
857
0
803
750
750
696
696
643
643
0
589
0
536
0
482
0
428
0
375
37504280482053605890643643696696750750803085706,839018,22618,22618,9666219,70519,70520,39215621,07821,07825125129929934634639439444144148948953653658458422,44663167967916,9747268828824,8239189539539889881,0231,0231,0591,0591,1001,1001,1291,1421,1831,1831,2001,2090000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
1,209
1,209
1,183
1,183
1,378
1,378
1,336
1,336
1,304
1,304
1,334
1,334
1,299
1,299
2,649
2,649
5,365
5,365
11,557
11,557
17,831
17,831
20,718
20,718
23,408
23,408
24,826
24,826
24,767
24,767
24,670
24,670
24,509
24,509
24,347
24,347
23,137
23,137
22,450
22,450
21,764
21,764
21,078
21,078
20,392
20,392
19,705
19,705
18,966
18,966
18,226
18,226
6,931
6,931
2,525
1,668
2,684
1,881
2,609
1,859
2,587
1,891
1,990
1,990
2,394
2,394
2,117
2,117
2,089
2,089
1,874
1,874
1,730
1,730
1,7301,7301,8741,8742,0892,0892,1172,1172,3942,3941,9901,9901,8912,5871,8592,6091,8812,6841,6682,5256,9316,93118,22618,22618,96618,96619,70519,70520,39220,39221,07821,07821,76421,76422,45022,45023,13723,13724,34724,34724,50924,50924,67024,67024,76724,76724,82624,82623,40823,40820,71820,71817,83117,83111,55711,5575,3655,3652,6492,6491,2991,2991,3341,3341,3041,3041,3361,3361,3781,3781,1831,1831,2091,2090000000000
> Total Liabilities 
741
0
0
871
0
0
0
1,181
1,035
1,035
1,349
1,349
1,834
1,834
1,611
1,612
1,495
1,495
2,651
2,651
1,631
1,631
2,123
2,123
2,193
2,193
3,158
3,158
4,504
4,504
3,727
3,727
1,946
1,946
3,136
3,136
30,936
30,936
13,283
13,283
4,677
4,677
5,396
5,396
4,441
4,441
6,142
6,142
18,038
18,038
11,164
11,164
9,390
9,390
7,870
7,870
9,100
9,100
9,482
9,482
8,015
8,015
3,381
3,381
1,846
1,846
2,519
2,519
1,870
1,870
2,497
2,497
4,447
4,447
0
4,987
0
5,636
0
4,856
0
4,013
0
5,212
5,21204,01304,85605,63604,98704,4474,4472,4972,4971,8701,8702,5192,5191,8461,8463,3813,3818,0158,0159,4829,4829,1009,1007,8707,8709,3909,39011,16411,16418,03818,0386,1426,1424,4414,4415,3965,3964,6774,67713,28313,28330,93630,9363,1363,1361,9461,9463,7273,7274,5044,5043,1583,1582,1932,1932,1232,1231,6311,6312,6512,6511,4951,4951,6121,6111,8341,8341,3491,3491,0351,0351,18100087100741
   > Total Current Liabilities 
741
0
0
871
0
0
0
1,181
1,035
1,035
1,327
1,327
1,809
1,809
1,581
1,581
1,466
1,466
2,600
2,600
1,585
1,585
2,061
2,061
2,124
2,124
3,074
3,074
4,380
4,380
3,681
3,681
1,878
1,878
1,975
1,975
24,815
24,815
7,736
7,736
1,619
1,619
1,878
1,878
1,242
1,242
3,262
3,262
13,160
13,160
6,056
6,056
4,341
4,341
3,202
3,202
5,060
5,060
5,738
5,738
4,837
4,837
3,362
3,362
1,821
1,821
2,484
2,484
1,828
1,828
2,416
2,416
2,149
2,149
2,665
2,665
3,384
3,384
2,766
2,766
2,005
2,005
3,318
3,318
3,3183,3182,0052,0052,7662,7663,3843,3842,6652,6652,1492,1492,4162,4161,8281,8282,4842,4841,8211,8213,3623,3624,8374,8375,7385,7385,0605,0603,2023,2024,3414,3416,0566,05613,16013,1603,2623,2621,2421,2421,8781,8781,6191,6197,7367,73624,81524,8151,9751,9751,8781,8783,6813,6814,3804,3803,0743,0742,1242,1242,0612,0611,5851,5852,6002,6001,4661,4661,5811,5811,8091,8091,3271,3271,0351,0351,18100087100741
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167
0
0
0
185
0
0
0
224
224000185000167000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
680
0
0
503
0
0
0
956
733
733
880
880
0
0
603
603
1,264
1,264
833
833
1,400
1,400
549
549
1,932
1,932
642
642
4,139
4,139
1,089
1,089
1,591
1,591
321
321
4,564
4,564
218
218
935
935
193
193
897
897
135
135
2,148
2,148
217
217
0
0
106
106
0
0
606
606
0
0
564
564
0
0
731
731
0
0
901
901
0
0
1,025
1,025
0
0
312
312
0
0
789
789
78978900312312001,0251,0250090190100731731005645640060660600106106002172172,1482,1481351358978971931939359352182184,5644,5643213211,5911,5911,0891,0894,1394,1396426421,9321,9325495491,4001,4008338331,2641,2646036030088088073373395600050300680
       Other Current Liabilities 
61
0
0
367
0
0
0
225
302
302
447
447
1,809
1,809
977
978
202
202
1,767
1,767
185
185
1,512
1,512
192
192
2,432
2,432
241
241
2,592
2,592
287
287
1,654
1,654
20,251
20,251
7,518
7,518
684
684
1,685
1,685
345
345
3,127
3,127
11,012
11,012
5,839
5,839
4,341
4,341
3,096
3,096
5,060
5,060
5,132
5,132
4,837
4,837
2,798
2,798
1,821
1,821
1,235
1,753
1,353
1,353
968
1,515
1,485
1,485
853
1,473
2,550
2,550
1,468
2,269
949
949
1,430
2,305
2,3051,4309499492,2691,4682,5502,5501,4738531,4851,4851,5159681,3531,3531,7531,2351,8211,8212,7982,7984,8374,8375,1325,1325,0605,0603,0963,0964,3414,3415,8395,83911,01211,0123,1273,1273453451,6851,6856846847,5187,51820,25120,2511,6541,6542872872,5922,5922412412,4322,4321921921,5121,5121851851,7671,7672022029789771,8091,8094474473023022250003670061
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
22
0
0
0
31
0
0
0
51
0
0
0
62
0
0
0
84
0
0
0
46
0
0
0
1,161
0
0
0
5,547
0
0
0
3,518
0
0
0
2,880
0
0
0
5,108
0
0
0
4,668
0
0
0
3,744
0
0
0
19
0
0
0
35
0
0
0
81
0
0
0
2,322
0
0
0
2,090
0
0
0
1,894
1,8940002,0900002,3220008100035000190003,7440004,6680005,1080002,8800003,5180005,5470001,16100046000840006200051000310002200000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,218
0
2,234
0
2,145
0
2,049
0
1,970
0
1,854
1,85401,97002,04902,14502,23402,2180000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
22
22
26
26
31
31
29
29
51
51
46
46
62
62
69
69
84
84
124
124
46
46
68
68
67
67
71
71
52
52
61
61
14
14
20
20
20
20
10
10
11
11
15
15
19
19
16
16
17
17
13
13
19
19
25
25
35
35
42
42
81
81
80
80
88
88
107
107
41
41
38
38
40
40
404038384141107107888880808181424235352525191913131717161619191515111110102020202014146161525271716767686846461241248484696962624646515129293131262622220000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,839
6,839
857
857
803
803
750
750
696
696
643
643
589
589
536
536
482
482
428
428
375
375
3753754284284824825365365895896436436966967507508038038578576,8396,83900000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
11,278
0
0
17,485
0
0
0
11,638
9,628
9,628
8,385
8,409
31,635
31,635
29,482
29,482
26,258
26,258
20,582
20,583
18,451
18,451
18,246
18,246
41,328
41,328
38,109
38,109
34,607
34,607
31,223
31,223
30,364
30,364
80,469
80,469
144,609
144,609
45,712
45,712
50,808
50,808
53,103
53,103
41,928
41,928
46,753
46,753
58,659
58,659
42,057
42,057
35,753
35,753
40,625
40,625
40,605
40,605
43,889
43,889
50,444
50,444
43,925
43,925
35,315
35,315
29,971
29,971
26,603
26,603
21,936
21,936
15,635
15,635
0
12,849
0
11,984
0
18,471
0
13,148
0
9,090
9,090013,148018,471011,984012,849015,63515,63521,93621,93626,60326,60329,97129,97135,31535,31543,92543,92550,44450,44443,88943,88940,60540,60540,62540,62535,75335,75342,05742,05758,65958,65946,75346,75341,92841,92853,10353,10350,80850,80845,71245,712144,609144,60980,46980,46930,36430,36431,22331,22334,60734,60738,10938,10941,32841,32818,24618,24618,45118,45120,58320,58226,25826,25829,48229,48231,63531,6358,4098,3859,6289,62811,63800017,4850011,278
   Common Stock
15,338
0
0
24,689
0
0
0
24,789
24,966
24,966
25,766
25,766
52,754
52,754
52,883
52,883
53,340
53,340
53,340
53,340
54,865
54,865
58,813
58,813
83,083
83,083
83,135
83,135
83,212
83,212
83,211
83,211
84,378
84,378
85,786
85,786
93,170
93,170
95,825
95,825
95,825
95,825
95,825
95,825
95,825
95,825
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,873
95,879
95,879
95,895
95,895
96,137
96,137
102,852
102,852
114,213
114,213
114,272
114,272
114,563
114,563
114,563114,563114,272114,272114,213114,213102,852102,85296,13796,13795,89595,89595,87995,87995,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,87395,82595,82595,82595,82595,82595,82595,82595,82593,17093,17085,78685,78684,37884,37883,21183,21183,21283,21283,13583,13583,08383,08358,81358,81354,86554,86553,34053,34053,34053,34052,88352,88352,75452,75425,76625,76624,96624,96624,78900024,6890015,338
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
-543
0
0
0
-873
0
0
0
2,106
0
0
0
1,010
0
0
0
1,570
0
0
0
1,953
0
0
0
2,061
0
0
0
4
0
0
0
4
0
0
0
-1,190
0
0
0
638
0
0
0
1,194
0
0
0
1,454
0
0
0
1,215
0
0
0
581
0
0
0
639
0
0
0
582
0
0
0
8,147
0
0
0
8,250
8,2500008,1470005820006390005810001,2150001,4540001,194000638000-1,190000400040002,0610001,9530001,5700001,0100002,106000-873000-54300000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
567
0
0
0
873
0
0
0
3,329
0
0
0
2,276
0
0
0
2,764
0
0
0
3,413
0
0
0
3,713
0
0
0
1,462
0
0
0
1,448
0
0
0
1,190
0
0
0
726
0
0
0
2,434
0
0
0
2,760
1,271
1,271
1,215
2,506
1,299
1,299
581
2,100
523
523
639
2,477
575
575
582
2,797
788
788
757
757
8,238
8,238
860
860
8608608,2388,2387577577887882,7975825755752,4776395235232,1005811,2991,2992,5061,2151,2711,2712,7600002,4340007260001,1900001,4480001,4620003,7130003,4130002,7640002,2760003,32900087300056700000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.